TY - JOUR
T1 - Establishing and augmenting views on the acceptability of a paediatric critical care randomised controlled trial (the FEVER trial)
T2 - A mixed methods study
AU - Deja, Elizabeth
AU - Peters, Mark J.
AU - Khan, Imran
AU - Mouncey, Paul R.
AU - Agbeko, Rachel
AU - Fenn, Blaise
AU - Watkins, Jason
AU - Ramnarayan, Padmanabhan
AU - Tibby, Shane M.
AU - Thorburn, Kentigern
AU - Tume, Lyvonne N.
AU - Rowan, Kathryn M.
AU - Woolfall, Kerry
N1 - Funding Information:
Contributors ED conducted the mixed methods research, co-analysed the data, drafted the initial manuscript, and reviewed and revised the manuscript. MJP is the chief investigator of the FEVER study, conceived, designed and oversaw conduct of the FEVER study and critically reviewed the manuscript. IK was the study manager at the ICNARC CTU responsible for day to day FEVER study management and critically reviewed the manuscript. PRM is the head of research at ICNARC CTU, a co-applicant, involved in the design and coordination of the FEVER study, contributed to and reviewed the manuscript. BF and JW were study co-applicants, patient and parent representatives who contributed to the design and conduct of the FEVER study, including mixed methods perspectives elements. PR, a co-applicant, helped design and conduct the FEVER study. RA, SMT and LNT were co-applicants, site principal investigators and critically reviewed the manuscript. KT was the site principal investigator and critically reviewed the manuscript. KMR is the director at ICNARC CTU, study co-applicant involved in designing and overseeing the FEVER study. KW was a co-applicant on the FEVER study, designed the mixed methods perspectives elements of the FEVER study, supervised the mixed methods research, co-analysed the data and reviewed and revised the manuscript. Funding This study was funded by the UK National Institute for Health Research Health Technology Assessment programme (15/44/01) and supported by the National Institute for Health Research, Great Ormond Street Hospital Biomedical Research Centre. The trial sponsor was Great Ormond Street Hospital NHS Foundation Trust, Joint R&D Office GOSH/ICH, 30 Guilford Street, London WC1N 1EH, UK ([email protected]). The Clinical Trials Unit for the FEVER study was the ICNARC CTU. The views expressed in this publication are those of the authors and not necessarily of the funder, the sponsor, the NHS, the NIHR or the UK Department of Health.
Publisher Copyright:
© 2021 The Author(s). Published by Cambridge University Press.
PY - 2021/3/10
Y1 - 2021/3/10
N2 - Objective To explore parent and staff views on the acceptability of a randomised controlled trial investigating temperature thresholds for antipyretic intervention in critically ill children with fever and infection (the FEVER trial) during a multi-phase pilot study. Design Mixed methods study with data collected at three time points: (1) before, (2) during and (3) after a pilot trial. Setting English, Paediatric Intensive Care Units (PICUs). Participants (1) Pre-pilot trial focus groups with pilot site staff (n=56) and interviews with parents (n=25) whose child had been admitted to PICU in the last 3 years with a fever and suspected infection, (2) Questionnaires with parents of randomised children following pilot trial recruitment (n=48 from 47 families) and (3) post-pilot trial interviews with parents (n=19), focus groups (n=50) and a survey (n=48) with site staff. Analysis drew on Sekhon et al's theoretical framework of acceptability. Results There was initial support for the trial, yet some held concerns regarding the proposed temperature thresholds and not using paracetamol for pain or discomfort. Pre-trial findings informed protocol changes and training, which influenced views on trial acceptability. Staff trained by the FEVER team found the trial more acceptable than those trained by colleagues. Parents and staff found the trial acceptable. Some concerns about pain or discomfort during weaning from ventilation remained. Conclusions Pre-trial findings and pilot trial experience influenced acceptability, providing insight into how challenges may be overcome. We present an adapted theoretical framework of acceptability to inform future trial feasibility studies. Trial registration numbers ISRCTN16022198 and NCT03028818.
AB - Objective To explore parent and staff views on the acceptability of a randomised controlled trial investigating temperature thresholds for antipyretic intervention in critically ill children with fever and infection (the FEVER trial) during a multi-phase pilot study. Design Mixed methods study with data collected at three time points: (1) before, (2) during and (3) after a pilot trial. Setting English, Paediatric Intensive Care Units (PICUs). Participants (1) Pre-pilot trial focus groups with pilot site staff (n=56) and interviews with parents (n=25) whose child had been admitted to PICU in the last 3 years with a fever and suspected infection, (2) Questionnaires with parents of randomised children following pilot trial recruitment (n=48 from 47 families) and (3) post-pilot trial interviews with parents (n=19), focus groups (n=50) and a survey (n=48) with site staff. Analysis drew on Sekhon et al's theoretical framework of acceptability. Results There was initial support for the trial, yet some held concerns regarding the proposed temperature thresholds and not using paracetamol for pain or discomfort. Pre-trial findings informed protocol changes and training, which influenced views on trial acceptability. Staff trained by the FEVER team found the trial more acceptable than those trained by colleagues. Parents and staff found the trial acceptable. Some concerns about pain or discomfort during weaning from ventilation remained. Conclusions Pre-trial findings and pilot trial experience influenced acceptability, providing insight into how challenges may be overcome. We present an adapted theoretical framework of acceptability to inform future trial feasibility studies. Trial registration numbers ISRCTN16022198 and NCT03028818.
KW - medical education & training
KW - paediatric intensive & critical care
KW - paediatrics
KW - pain management
KW - qualitative research
UR - http://www.scopus.com/inward/record.url?scp=85102452357&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85102452357&partnerID=8YFLogxK
U2 - 10.1136/bmjopen-2020-041952
DO - 10.1136/bmjopen-2020-041952
M3 - Article (journal)
C2 - 33692177
AN - SCOPUS:85102452357
SN - 2044-6055
VL - 11
SP - e041952
JO - BMJ Open
JF - BMJ Open
IS - 3
M1 - e041952
ER -